None
Quote | Xencor Inc. (NASDAQ:XNCR)
Last: | $18.08 |
---|---|
Change Percent: | -2.85% |
Open: | $18.61 |
Close: | $18.61 |
High: | $18.61 |
Low: | $18.07 |
Volume: | 78,452 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Xencor Inc. (NASDAQ:XNCR)
2024-06-13 15:02:59 ET More on Xencor Seeking Alpha’s Quant Rating on Xencor Historical earnings data for Xencor Financial information for Xencor Read the full article on Seeking Alpha For further details see: Xencor to regain rights from J...
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, announced it will regain exclusive worldwide rights to plamotamab, a CD20 x CD3 bispecific T-cell engager, which Xencor advanced through ...
Message Board Posts | Xencor Inc. (NASDAQ:XNCR)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $XNCR News Article - Xencor to Host First Quarter 2023 Financial Results Webcast and Co | whytestocks | investorshangout | 05/01/2023 8:40:49 PM |
whytestocks: $XNCR News Article - Xencor Enters Global Collaboration and License Agreement With Jans | whytestocks | investorshangout | 10/04/2021 5:45:51 PM |
whytestocks: $XNCR News Article - Xencor Reports Second Quarter 2019 Financial Results | whytestocks | investorshangout | 08/06/2019 8:05:41 PM |
whytestocks: $XNCR News Article - Xencor Announces the Planned Retirement of Chief Medical Officer P | whytestocks | investorshangout | 06/27/2019 3:05:47 PM |
danrocks: XNCR Stock is number 184 for the largest percentage gain out of 250 stocks. $XNCR XNCR is | danrocks | investorshangout | 12/19/2015 4:26:50 AM |
News, Short Squeeze, Breakout and More Instantly...
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, announced it will regain exclusive worldwide rights to plamotamab, a CD20 x CD3 bispecific T-cell engager, which Xencor advanced through ...
2024-06-04 04:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-25 06:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...